08:10 AM EDT, 10/29/2026 (MT Newswires) -- EnSilica (ENSI.L) signed a $2.4 million application-specific integrated circuit, or ASIC, development and supply contract with a US healthcare technology company, following an initial feasibility study. The British fabless semiconductor company will develop a wireless biosensing and therapeutic controller ASIC, according to a Thursday release. The project is expected to run for 18 months, with a framework covering the supply throughout the product's commercial lifetime. EnSilica also wrapped up the tape-out of an ASIC for a UK-listed life-sciences technology company under a separate $1.6 million contract. The design is now moving to fabrication at a foundry.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.